Maeda, Daichi
Kagiyama, Nobuyuki
Jujo, Kentaro
Saito, Kazuya
Kamiya, Kentaro
Saito, Hiroshi
Ogasahara, Yuki
Maekawa, Emi
Konishi, Masaaki
Kitai, Takeshi
Iwata, Kentaro
Wada, Hiroshi
Hiki, Masaru
Dotare, Taishi
Sunayama, Tsutomu
Kasai, Takatoshi
Nagamatsu, Hirofumi
Ozawa, Tetsuya
Izawa, Katsuya
Yamamoto, Shuhei
Aizawa, Naoki
Yonezawa, Ryusuke
Oka, Kazuhiro
Momomura, Shin-ichi
Matsue, Yuya
Funding for this research was provided by:
Japan Heart Foundation
NOVARTIS Foundation (Japan) for the Promotion of Science
Japan Society for the Promotion of Science (18K15862)
Article History
Received: 25 February 2021
Accepted: 24 May 2021
First Online: 7 June 2021
Competing interests
: Dr. Yuya Matsue and Takatoshi Kasai are affiliated with a department endowed by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi, and Dr. Yuya Matsue received an honorarium from Otsuka Pharmaceutical Co., Ltd., and Novartis Japan. Dr. Kagiyama reports grants from Philips, Asahi KASEI Corporation, Toho Holdings Co., Ltd, and Inter Reha Co., Ltd. outside the submitted work. Dr. Kamiya has received research funding from Eiken Chemical Co. Ltd. Other authors have nothing to declare.